Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...

In 2022, the combined research and development (R&D) expenditure of the U.S. pharmaceutical industry consisted of more than $100 billion. While this is a significantly expansive market, approximately ...

Forbes contributors publish independent expert analyses and insights. Gary Drenik is a writer covering AI, analytics and innovation. Innovation is increasingly intertwined with advancements in ...

I had a fascinating conversation recently with someone from the pharmaceutical industry. We talked about the rise of GLP-1 medications that are now widely known for their impact on weight loss and ...

R&D can’t live in a lab anymore. Today’s leaders fuse science, strategy, sustainability and people to turn discovery into real-world value.

Over the past decade, total U.S. expenditure on research and development (R&D) has nearly doubled. However, this growth has been unequal across performing sectors (public, private, academic, and ...

Research and development efforts drive economic growth, spur technological innovation, raise living standards, and improve human health. 26 Institutions of higher education spent $109 billion on R&D ...